| 000 | 01669 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514193447.0 | ||
| 264 | 0 | _c20041026 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a0312-5963 | ||
| 024 | 7 |
_a10.2165/00003088-200443100-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGimenez, François | |
| 245 | 0 | 0 |
_aEvaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _c2004 |
||
| 300 |
_a685-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcyclovir _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aGlucuronides _xmetabolism |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aValacyclovir |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 700 | 1 | _aFoeillet, Estelle | |
| 700 | 1 | _aBourdon, Olivier | |
| 700 | 1 | _aWeller, Steve | |
| 700 | 1 | _aGarret, Christophe | |
| 700 | 1 | _aBidault, Roselyne | |
| 700 | 1 | _aSinglas, Eric | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 43 _gno. 10 _gp. 685-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-200443100-00004 _zAvailable from publisher's website |
| 999 |
_c14947746 _d14947746 |
||